Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Anne Kallioniemi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Physiology
Disorders
Procedures
Anatomy
Concepts & Ideas
Devices
Phenomena
Chemicals & Drugs
Genes & Molecular Sequences
Sign-in to see full Profile
Network (preview)
38
Kallioniemi, Olli
22
Karhu, Ritva
16
Monni, Outi
13
Pinkel, Daniel
13
Sauter, Guido
13
Waldman, Frederic
12
Kauraniemi, Päivikki
12
Bärlund, Maarit
12
Gray, Joe
9
Kuukasjärvi, Tuula
8
Kononen, Juha
8
Syrjäkoski, Kirsi
8
Mousses, Spyro
7
Alarmo, Emma-Leena
7
Isola, Jorma
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Anne Kallioniemi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Laurila Eeva; Savinainen Kimmo; Kuuselo Riina; Karhu Ritva; Kallioniemi Anne
Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
Genes, chromosomes & cancer 2009;48(4):330-9.
-
2009: Alarmo Emma-Leena; Pärssinen Jenita; Ketolainen Johanna M; Savinainen Kimmo; Karhu Ritva; Kallioniemi Anne
BMP7 influences proliferation, migration, and invasion of breast cancer cells.
Cancer letters 2009;275(1):35-43.
-
2008: Erkko Hannele; Dowty James G; Nikkilä Jenni; Syrjäkoski Kirsi; Mannermaa Arto; Pylkäs Katri; Southey Melissa C; Holli Kaija; Kallioniemi Anne; Jukkola-Vuorinen Arja; Kataja Vesa; Kosma Veli-Matti; Xia Bing; Livingston David M; Winqvist Robert; Hopper John L
Penetrance analysis of the PALB2 c.1592delT founder mutation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4667-71.
-
2008: Fagerholm Rainer; Hofstetter Barbara; Tommiska Johanna; Aaltonen Kirsimari; Vrtel Radek; Syrjäkoski Kirsi; Kallioniemi Anne; Kilpivaara Outi; Mannermaa Arto; Kosma Veli-Matti; Uusitupa Matti; Eskelinen Matti; Kataja Vesa; Aittomäki Kristiina; von Smitten Karl; Heikkilä Päivi; Lukas Jiri; Holli Kaija; Bartkova Jirina; Blomqvist Carl; Bartek Jiri; Nevanlinna Heli
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
Nature genetics 2008;40(7):844-53.
-
2008: Pärssinen Jenita; Alarmo Emma-Leena; Karhu Ritva; Kallioniemi Anne
PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53.
Cancer genetics and cytogenetics 2008;182(1):33-9.
-
2008: Kallioniemi Anne
CGH microarrays and cancer.
Current opinion in biotechnology 2008;19(1):36-40.
-
2008: Alarmo E-L; Korhonen T; Kuukasjärvi T; Huhtala H; Holli K; Kallioniemi A
Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):308-14.
-
2008: Pärssinen Jenita; Alarmo Emma-Leena; Khan Sofia; Karhu Ritva; Vihinen Mauno; Kallioniemi Anne
Identification of differentially expressed genes after PPM1D silencing in breast cancer.
Cancer letters 2008;259(1):61-70.
-
2008: Heinonen Henna; Nieminen Anni; Saarela Matti; Kallioniemi Anne; Klefström Juha; Hautaniemi Sampsa; Monni Outi
Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer.
BMC genomics 2008;9():348.
-
2008: Lind Guro E; Ahlquist Terje; Kolberg Matthias; Berg Marianne; Eknaes Mette; Alonso Miguel A; Kallioniemi Anne; Meling Gunn I; Skotheim Rolf I; Rognum Torleiv O; Thiis-Evensen Espen; Lothe Ragnhild A
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.
Journal of translational medicine 2008;6():13.
-
2007: Alarmo Emma-Leena; Kuukasjärvi Tuula; Karhu Ritva; Kallioniemi Anne
A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.
Breast cancer research and treatment 2007;103(2):239-46.
-
2007: Pärssinen J; Kuukasjärvi T; Karhu R; Kallioniemi A
High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer.
British journal of cancer 2007;96(8):1258-64.
-
2007: Kuuselo Riina; Savinainen Kimmo; Azorsa David O; Basu Gargi D; Karhu Ritva; Tuzmen Sukru; Mousses Spyro; Kallioniemi Anne
Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
Cancer research 2007;67(5):1943-9.
-
2007: Erkko Hannele; Xia Bing; Nikkilä Jenni; Schleutker Johanna; Syrjäkoski Kirsi; Mannermaa Arto; Kallioniemi Anne; Pylkäs Katri; Karppinen Sanna-Maria; Rapakko Katrin; Miron Alexander; Sheng Qing; Li Guilan; Mattila Henna; Bell Daphne W; Haber Daniel A; Grip Mervi; Reiman Mervi; Jukkola-Vuorinen Arja; Mustonen Aki; Kere Juha; Aaltonen Lauri A; Kosma Veli-Matti; Kataja Vesa; Soini Ylermi; Drapkin Ronny I; Livingston David M; Winqvist Robert
A recurrent mutation in PALB2 in Finnish cancer families.
Nature 2007;446(7133):316-9.
-
2007: Syrjäkoski Kirsi; Jäntti Jussi; Kallioniemi Anne; Karhu Ritva
Mutations in the BRCA2 interacting DSS1 are not a risk factor for male breast cancer.
International journal of cancer. Journal international du cancer 2007;120(2):444-6.
-
2006: Karppinen S-M; Barkardottir R B; Backenhorn K; Sydenham T; Syrjäkoski K; Schleutker J; Ikonen T; Pylkäs K; Rapakko K; Erkko H; Johannesdottir G; Gerdes A-M; Thomassen M; Agnarsson B A; Grip M; Kallioniemi A; Kere J; Aaltonen L A; Arason A; Møller P; Kruse T A; Borg A; Winqvist R
Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.
Journal of medical genetics 2006;43(11):856-62.
-
2006: Karhu Ritva; Mahlamäki Eija; Kallioniemi Anne
Pancreatic adenocarcinoma -- genetic portrait from chromosomes to microarrays.
Genes, chromosomes & cancer 2006;45(8):721-30.
-
2006: Alarmo Emma-Leena; Rauta Jenita; Kauraniemi Päivikki; Karhu Ritva; Kuukasjärvi Tuula; Kallioniemi Anne
Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.
Genes, chromosomes & cancer 2006;45(4):411-9.
-
2006: Kauraniemi P; Kallioniemi A
Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.
Endocrine-related cancer 2006;13(1):39-49.
-
2006: Rauta Jenita; Alarmo Emma-Leena; Kauraniemi Päivikki; Karhu Ritva; Kuukasjärvi Tuula; Kallioniemi Anne
The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours.
Breast cancer research and treatment 2006;95(3):257-63.
-
2006: Karhu Ritva; Laurila Eeva; Kallioniemi Anne; Syrjäkoski Kirsi
Large genomic BRCA2 rearrangements and male breast cancer.
Cancer detection and prevention 2006;30(6):530-4.
-
2005: Laurila Eeva; Syrjäkoski Kirsi; Holli Kaija; Kallioniemi Anne; Karhu Ritva
Search for large genomic alterations of the BRCA1 gene in a Finnish population.
Cancer genetics and cytogenetics 2005;163(1):57-61.
-
2004: Bärlund Maarit; Kuukasjärvi Tuula; Syrjäkoski Kirsi; Auvinen Anssi; Kallioniemi Anne
Frequent amplification and overexpression of CCND1 in male breast cancer.
International journal of cancer. Journal international du cancer 2004;111(6):968-71.
-
2004: Mahlamäki Eija H; Kauraniemi Päivikki; Monni Outi; Wolf Maija; Hautaniemi Sampsa; Kallioniemi Anne
High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer.
Neoplasia (New York, N.Y.) 2004;6(5):432-9.
-
2004: Wolf Maija; Mousses Spyro; Hautaniemi Sampsa; Karhu Ritva; Huusko Pia; Allinen Minna; Elkahloun Abdel; Monni Outi; Chen Yidong; Kallioniemi Anne; Kallioniemi Olli-P
High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression.
Neoplasia (New York, N.Y.) 2004;6(3):240-7.
-
2004: Kauraniemi Päivikki; Hautaniemi Sampsa; Autio Reija; Astola Jaakko; Monni Outi; Elkahloun Abdel; Kallioniemi Anne
Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines.
Oncogene 2004;23(4):1010-3.
-
2003: Skotheim Rolf I; Kallioniemi Anne; Bjerkhagen Bodil; Mertens Fredrik; Brekke Helge R; Monni Outi; Mousses Spyro; Mandahl Nils; Soeter Gunnar; Nesland Jahn M; Smeland Sigbjørn; Kallioniemi Olli-P; Lothe Ragnhild A
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4586-91.
-
2003: Kauraniemi Päivikki; Kuukasjärvi Tuula; Sauter Guido; Kallioniemi Anne
Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer.
The American journal of pathology 2003;163(5):1979-84.
-
2003: Autio Reija; Hautaniemi Sampsa; Kauraniemi Päivikki; Yli-Harja Olli; Astola Jaakko; Wolf Maija; Kallioniemi Anne
CGH-Plotter: MATLAB toolbox for CGH-data analysis.
Bioinformatics (Oxford, England) 2003;19(13):1714-5.
-
2002: Mahlamäki Eija H; Bärlund Maarit; Tanner Minna; Gorunova Ludmila; Höglund Mattias; Karhu Ritva; Kallioniemi Anne
Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
Genes, chromosomes & cancer 2002;35(4):353-8.
-
2002: Bärlund Maarit; Monni Outi; Weaver J Donald; Kauraniemi Päivikki; Sauter Guido; Heiskanen Mervi; Kallioniemi Olli-P; Kallioniemi Anne
Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Genes, chromosomes & cancer 2002;35(4):311-7.
-
2002: Hyman Elizabeth; Kauraniemi Päivikki; Hautaniemi Sampsa; Wolf Maija; Mousses Spyro; Rozenblum Ester; Ringnér Markus; Sauter Guido; Monni Outi; Elkahloun Abdel; Kallioniemi Olli-P; Kallioniemi Anne
Impact of DNA amplification on gene expression patterns in breast cancer.
Cancer research 2002;62(21):6240-5.
-
2002: Andersen Claus L; Monni Outi; Wagner Urs; Kononen Juha; Bärlund Maarit; Bucher Christoph; Haas Philippe; Nocito Antonio; Bissig Heidi; Sauter Guido; Kallioniemi Anne
High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays.
The American journal of pathology 2002;161(1):73-9.
-
2002: Bulavin Dmitry V; Demidov Oleg N; Saito Shin'ichi; Kauraniemi Paivikki; Phillips Crissy; Amundson Sally A; Ambrosino Concetta; Sauter Guido; Nebreda Angel R; Anderson Carl W; Kallioniemi Anne; Fornace Albert J; Appella Ettore
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.
Nature genetics 2002;31(2):210-5.
-
2002: Varis Asta; Wolf Maija; Monni Outi; Vakkari Marja-Leena; Kokkola Arto; Moskaluk Chris; Frierson Henry; Powell Steven M; Knuutila Sakari; Kallioniemi Anne; El-Rifai Wa'el
Targets of gene amplification and overexpression at 17q in gastric cancer.
Cancer research 2002;62(9):2625-9.
-
2002: Skotheim Rolf I; Monni Outi; Mousses Spyro; Fosså Sophie D; Kallioniemi Olli-P; Lothe Ragnhild A; Kallioniemi Anne
New insights into testicular germ cell tumorigenesis from gene expression profiling.
Cancer research 2002;62(8):2359-64.
-
2002: Mousses Spyro; Kallioniemi Anne; Kauraniemi Päivikki; Elkahloun Abdel; Kallioniemi Olli-P
Clinical and functional target validation using tissue and cell microarrays.
Current opinion in chemical biology 2002;6(1):97-101.
-
2001: Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Cancer research 2001;61(22):8235-40.
-
2001: Andersen C L; Hostetter G; Grigoryan A; Sauter G; Kallioniemi A
Improved procedure for fluorescence in situ hybridization on tissue microarrays.
Cytometry 2001;45(2):83-6.
-
2001: Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi O P
From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
Seminars in cancer biology 2001;11(5):395-401.
-
2001: Monni O; Barlund M; Mousses S; Kononen J; Sauter G; Heiskanen M; Paavola P; Avela K; Chen Y; Bittner M L; Kallioniemi A
Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(10):5711-6.
-
2001: Heiskanen M; Kononen J; Bärlund M; Torhorst J; Sauter G; Kallioniemi A; Kallioniemi O
CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2001;22(4):229-34.
-
2000: Wolf M; El-Rifai W; Tarkkanen M; Kononen J; Serra M; Eriksen E F; Elomaa I; Kallioniemi A; Kallioniemi O P; Knuutila S
Novel findings in gene expression detected in human osteosarcoma by cDNA microarray.
Cancer genetics and cytogenetics 2000;123(2):128-32.
-
2000: Bärlund M; Monni O; Kononen J; Cornelison R; Torhorst J; Sauter G; Kallioniemi OLLI-P; Kallioniemi A
Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.
Cancer research 2000;60(19):5340-4.
-
2000: Forozan F; Mahlamäki E H; Monni O; Chen Y; Veldman R; Jiang Y; Gooden G C; Ethier S P; Kallioniemi A; Kallioniemi O P
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.
Cancer research 2000;60(16):4519-25.
-
2000: Bärlund M; Forozan F; Kononen J; Bubendorf L; Chen Y; Bittner M L; Torhorst J; Haas P; Bucher C; Sauter G; Kallioniemi O P; Kallioniemi A
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.
Journal of the National Cancer Institute 2000;92(15):1252-9.
-
1999: Forozan F; Veldman R; Ammerman C A; Parsa N Z; Kallioniemi A; Kallioniemi O P; Ethier S P
Molecular cytogenetic analysis of 11 new breast cancer cell lines.
British journal of cancer 1999;81(8):1328-34.
-
1999: Paavola P; Avela K; Horelli-Kuitunen N; Bärlund M; Kallioniemi A; Idänheimo N; Kyttälä M; de la Chapelle A; Palotie A; Lehesjoki A E; Peltonen L
High-resolution physical and genetic mapping of the critical region for Meckel syndrome and Mulibrey Nanism on chromosome 17q22-q23.
Genome research 1999;9(3):267-76.
-
1999: Vidgren V; Varis A; Kokkola A; Monni O; Puolakkainen P; Nordling S; Forozan F; Kallioniemi A; Vakkari M L; Kivilaakso E; Knuutila S
Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer.
Genes, chromosomes & cancer 1999;24(1):24-9.
-
1998: Kononen J; Bubendorf L; Kallioniemi A; Bärlund M; Schraml P; Leighton S; Torhorst J; Mihatsch M J; Sauter G; Kallioniemi O P
Tissue microarrays for high-throughput molecular profiling of tumor specimens.
Nature medicine 1998;4(7):844-7.
-
1998: Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi O P
Molecular cytogenetics of primary breast cancer by CGH.
Genes, chromosomes & cancer 1998;21(3):177-84.
-
1998: Nupponen N N; Hyytinen E R; Kallioniemi A H; Visakorpi T
Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization.
Cancer genetics and cytogenetics 1998;101(1):53-7.
-
1998: Bärlund M; Nupponen N N; Karhu R; Tanner M M; Paavola P; Kallioniemi O P; Kallioniemi A
Molecular cytogenetic mapping of 24 CEPH YACs and 24 gene-specific large insert probes to chromosome 17.
Cytogenetics and cell genetics 1998;82(3-4):189-91.
-
1997: Bärlund M; Tirkkonen M; Forozan F; Tanner M M; Kallioniemi O; Kallioniemi A
Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.
Genes, chromosomes & cancer 1997;20(4):372-6.
-
1997: Forozan F; Karhu R; Kononen J; Kallioniemi A; Kallioniemi O P
Genome screening by comparative genomic hybridization.
Trends in genetics : TIG 1997;13(10):405-9.
-
1997: Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi O P; Isola J
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
Cancer research 1997;57(8):1597-604.
-
1996: Tanner M M; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan X Y; Trent J; Gray J W; Meltzer P; Kallioniemi O P
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
Cancer research 1996;56(15):3441-5.
-
1996: Deng G; Yu M; Chen L C; Moore D; Kurisu W; Kallioniemi A; Waldman F M; Collins C; Smith H S
Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction.
Breast cancer research and treatment 1996;40(3):271-81.
-
1995: Tanner M M; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray J W; Kallioniemi O P; Isola J
Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(12):1455-61.
-
1995: Bryndorf T; Kirchhoff M; Rose H; Maahr J; Gerdes T; Karhu R; Kallioniemi A; Christensen B; Lundsteen C; Philip J
Comparative genomic hybridization in clinical cytogenetics.
American journal of human genetics 1995;57(5):1211-20.
-
1995: Sauter G; Carroll P; Moch H; Kallioniemi A; Kerschmann R; Narayan P; Mihatsch M J; Waldman F M
c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
The American journal of pathology 1995;146(5):1131-9.
-
1995: Tarkkanen M; Karhu R; Kallioniemi A; Elomaa I; Kivioja A H; Nevalainen J; Böhling T; Karaharju E; Hyytinen E; Knuutila S
Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization.
Cancer research 1995;55(6):1334-8.
-
1995: Stokke T; Collins C; Kuo W L; Kowbel D; Shadravan F; Tanner M; Kallioniemi A; Kallioniemi O P; Pinkel D; Deaven L
A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis.
Genomics 1995;26(1):134-7.
-
1995: Kallioniemi A; Kallioniemi O P; Citro G; Sauter G; DeVries S; Kerschmann R; Caroll P; Waldman F
Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization.
Genes, chromosomes & cancer 1995;12(3):213-9.
-
1995: Piper J; Rutovitz D; Sudar D; Kallioniemi A; Kallioniemi O P; Waldman F M; Gray J W; Pinkel D
Computer image analysis of comparative genomic hybridization.
Cytometry 1995;19(1):10-26.
-
1995: Visakorpi T; Kallioniemi A H; Syvänen A C; Hyytinen E R; Karhu R; Tammela T; Isola J J; Kallioniemi O P
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Cancer research 1995;55(2):342-7.
-
1994: Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi O P
Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
The American journal of pathology 1994;145(3):624-30.
-
1994: Tanner M M; Tirkkonen M; Kallioniemi A; Collins C; Stokke T; Karhu R; Kowbel D; Shadravan F; Hintz M; Kuo W L
Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.
Cancer research 1994;54(16):4257-60.
-
1994: Kallioniemi O P; Kallioniemi A; Piper J; Isola J; Waldman F M; Gray J W; Pinkel D
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.
Genes, chromosomes & cancer 1994;10(4):231-43.
-
1994: Hyytinen E; Visakorpi T; Kallioniemi A; Kallioniemi O P; Isola J J
Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Cytometry 1994;16(2):93-9.
-
1994: Kallioniemi A; Kallioniemi O P; Piper J; Tanner M; Stokke T; Chen L; Smith H S; Pinkel D; Gray J W; Waldman F M
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(6):2156-60.
-
1994: Kallioniemi O P; Kallioniemi A; Mascio L; Sudar D; Pinkel D; Deaven L; Gray J
Physical mapping of chromosome 17 cosmids by fluorescence in situ hybridization and digital image analysis.
Genomics 1994;20(1):125-8.
-
1994: Gray J W; Collins C; Henderson I C; Isola J; Kallioniemi A; Kallioniemi O P; Nakamura H; Pinkel D; Stokke T; Tanner M
Molecular cytogenetics of human breast cancer.
Cold Spring Harbor symposia on quantitative biology 1994;59():645-52.
-
1993: Mohamed A N; Macoska J A; Kallioniemi A; Kallioniemi O P; Waldman F; Ratanatharathorn V; Wolman S R
Extrachromosomal gene amplification in acute myeloid leukemia; characterization by metaphase analysis, comparative genomic hybridization, and semi-quantitative PCR.
Genes, chromosomes & cancer 1993;8(3):185-9.
-
1993: Kallioniemi O P; Kallioniemi A; Sudar D; Rutovitz D; Gray J W; Waldman F; Pinkel D
Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors.
Seminars in cancer biology 1993;4(1):41-6.
-
1992: Gray J W; Kallioniemi A; Kallioniemi O; Pallavicini M; Waldman F; Pinkel D
Molecular cytogenetics: diagnosis and prognostic assessment.
Current opinion in biotechnology 1992;3(6):623-31.
-
1992: Kallioniemi A; Kallioniemi O P; Sudar D; Rutovitz D; Gray J W; Waldman F; Pinkel D
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.
Science (New York, N.Y.) 1992;258(5083):818-21.
-
1992: Kallioniemi O P; Kallioniemi A; Kurisu W; Thor A; Chen L C; Smith H S; Waldman F M; Pinkel D; Gray J W
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(12):5321-5.
-
1992: Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith H S; Pinkel D; Gray J; Waldman F M
Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
Cancer research 1992;52(12):3474-7.
-
1992: Kallioniemi A; Kallioniemi O P; Waldman F M; Chen L C; Yu L C; Fung Y K; Smith H S; Pinkel D; Gray J W
Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization.
Cytogenetics and cell genetics 1992;60(3-4):190-3.
-
1991: Gray J W; Lucas J; Kallioniemi O; Kallioniemi A; Kuo W L; Straume T; Tkachuk D; Tenjin T; Weier H U; Pinkel D
Applications of fluorescence in situ hybridization in biological dosimetry and detection of disease-specific chromosome aberrations.
Progress in clinical and biological research 1991;372():399-411.
Sign-in to see more